跳至主要内容
临床试验/NCT02292030
NCT02292030Unknown不适用

Cardioversion of Atrial Fibrillation Accompanied by Chronic Heart Faliure With or Without HTEA

Harbin Medical University2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2014年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
60
试验地点
2
主要终点
recurrence of atrial fibrillation

研究概览

简要总结

The purpose of this study is to explore the efficacy of low energy cardioversion on atrial fibrillation accompanied with chronic heart failure treated with HTEA or usual medicine.

详细描述

The purpose of this study is to explore the efficacy of low energy (30J) cardioversion on atrial fibrillation accompanied with chronic heart failure treated with HTEA or usual medicine.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • congestive heart failure accompanied by atrial fibrillation.

排除标准

  • Valvular heart diseases.

研究组 & 干预措施

cardioversion+HTEA

Heart failure patients accompanied by atrial fibrillation receive the treatment of cardioversion+HTEA.

干预措施: HTEA (Drug)

only cardioversion

Heart failure patients accompanied by atrial fibrillation receive the treatment of cardioversion, but not with HTEA.

干预措施: HTEA (Drug)

结局指标

主要结局

recurrence of atrial fibrillation

时间窗: 1 year

次要结局

未报告次要终点

研究者

发起方
Harbin Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Wei Liu

Prof.

Harbin Medical University

研究点 (2)

Loading locations...

相似试验